tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK

Compare Cytokinetics (CYTK) vs. Competitors

1,245 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Cytokinetics
$65.77
$8.10B
-9.72
90.25%
15 Buy
2 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$173.19
$8.86B
-49.60
77.54%
16 Buy
1 Hold
0 Sell
Strong Buy
Rhythm Pharmaceuticals
$85.48
$5.84B
-35.39
48.07%
14 Buy
0 Hold
0 Sell
Strong Buy
Legend Biotech
$17.99
$3.38B
-32.35
-40.53%
10 Buy
2 Hold
0 Sell
Strong Buy
Atrium Therapeutics, Inc.
$13.99
-3.29
-7.12%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nuvalent
$102.25
$8.26B
-17.19
77.07%
15 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CYTK
Cytokinetics
65.77
28.45
76.23%
AXSM
Axsome Therapeutics
173.19
71.52
70.35%
RYTM
Rhythm Pharmaceuticals
85.48
25.25
41.92%
LEGN
Legend Biotech
18.30
-13.78
-42.96%
RNA
Atrium Therapeutics, Inc.
13.70
-1.05
-7.12%
NUVL
Nuvalent
105.04
40.34
62.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts